麝香保心丸联合盐酸曲美他嗪片治疗老年不稳定型心绞痛患者的疗效及对心功能、血脂水平的影响

摘要/Abstract

摘要： 目的探讨与分析麝香保心丸联合盐酸曲美他嗪片治疗不稳定型心绞痛老年患者的疗效及对心功能、血脂水平的影响。方法选取2020年3月—2021年3月甘肃省中医院诊治的不稳定型心绞痛老年患者180例作为研究对象,根据随机数表法把患者分为联合组与传统组,各90例。传统组给予盐酸曲美他嗪治疗,联合组在传统组治疗的基础上给予麝香保心丸治疗。判定两组患者治疗效果与主要心血管不良事件发生情况,检测心功能与血脂水平变化情况。结果治疗后,联合组治疗总有效率高于传统组,差异有统计学意义（P<0.05）。治疗后,联合组与传统组TC、TG与LDL-C水平均明显低于治疗前,HDL-C明显高于治疗前（P<0.05）;治疗后联合组TC、TG与LDL-C水平均明显低于传统组,HDL-C明显高于传统组,差异有统计学意义（P<0.05）。联合组与传统组治疗后的心室舒张末期内径与心室收缩末期内径均明显低于治疗前,左心室射血分数均高于治疗前（P<0.05）,治疗后联合组心室舒张末期内径与心室收缩末期内径都明显低于传统组,左心室射血分数高于传统组,差异有统计学意义（P<0.05）。治疗后随访1年,联合组的心力衰竭、心源性死亡、心肌梗死、再发心绞痛等主要心血管不良事件发生率低于传统组,但差异无统计学意义（P>0.05）。结论麝香保心丸联合盐酸曲美他嗪片治疗不稳定型心绞痛老年患者能改善患者的心功能,也能改善患者的血脂水平,有利于提高患者的总体治疗效果,且不会增加随访远期心血管不良事件发生率。

关键词: 麝香保心丸, 盐酸曲美他嗪, 老年人, 不稳定型心绞痛, 心功能, 血脂水平

Abstract: Objective To investigate and analysis the effects of Shexiang Baoxin Pill combined with trimetazidine hydrochloride tablets in the treatment of elderly patients with unstable angina pectoris and its influence on heart function and blood lipid level. Methods From March 2020 to March 2021, 180 cases of elderly patients with unstable angina pectoris diagnosed and treated in our hospital were selected as the study objects. Accorded to the random number table method, the patients were divided into the combined group and the traditional group with 90 cases in each groups. The traditional group was treated with trimetazidine hydrochloride, and the combined group was treated with Shexiang Baoxin Pill on the basis of the traditional group. All the cases were to determine the treatment effects and cardiovascular adverse events, and to detect the changes of cardiac function and blood lipid levels. Results After treatment, the total effective rates of the combined group were significantly higher than that of the traditional group ( P<0.05). The levels of TC, TG and LDL-C in the combined group and the traditional group after treatment were significantly lower than those before treatment (P<0.05), and HDL-C were also significantly higher than those before treatment (P<0.05). There were also significant difference compared between the combined group and the traditional group after treatment (P<0.05). The ventricular end diastolic diameter and ventricular end systolic diameter in the combined group and the traditional group after treatment were significantly lower than those before treatment, left ventricular ejection fraction were all higher than before treatment (P<0.05), and there were also significant difference compared between the combined group and the traditional group after treatment (P<0.05). At 1-year of follow-up after treatment, the incidence rates of major cardiovascular adverse events such as recurrent angina pectoris, myocardial infarction, cardiac death and heart failure was lower than in the traditional group, and the statistical analysis did not differ (P>0.05). Conclusion The combination of Shexiang Baoxin Pill and Trimetazidine Hydrochloride Tablets in the treatment of elderly patients with unstable angina pectoris can improve the cardiac function, improve the therapeutic effect, improve the blood lipid level of patients, and will not increase the incidence of cardiovascular adverse events.

Key words: shexiang baoxin pill, trimetazidine hydrochloride, aged, unstable angina pectoris, cardiac function, blood lipid level

中图分类号:

R256.22

何金丽. 麝香保心丸联合盐酸曲美他嗪片治疗老年不稳定型心绞痛患者的疗效及对心功能、血脂水平的影响[J]. 中华养生保健, 2023, 41(8): 29-32.

参考文献

[1] 鲁利甫,邱雪银,魏振国.当归四逆汤加减联合麝香保心丸治疗老年冠心病心绞痛疗效及对患者心电图、血清因子水平的影响[J].陕西中医,2019,40(5):587-590.
[2] 郭瑞霞,冯永萌,姚文哲,等.麝香保心丸联合替格瑞洛治疗冠心病心绞痛的临床研究[J].现代药物与临床,2022,37(1):81-85.
[3] 赵梦竹,张玉佳,程侣,等.麝香保心丸治疗冠心病的有效性及安全性的系统评价再评价[J].中国循证心血管医学杂志,2022,14(2):137-142,156.
[4] 李艳娟,王凤荣,陈星,等.冠心病心绞痛中医证候规范及心血瘀阻证计量研究[J].辽宁中医药大学学报,2016,18(3):63-66.
[5] 王鑫,刘爱香,李小军,等.麝香保心丸联合单硝酸异山梨酯片对不稳定型心绞痛患者心肌损伤标志物的影响[J].新中医,2022,54(11):65-70.
[6] 夏海江. 麝香通心滴丸联合常规西药治疗冠心病稳定型心绞痛临床研究[J].新中医,2022,54(8):64-67.
[7] 孙敏丽,曲晨,郭守玉.麝香保心丸通过改善血管内皮功能治疗冠状动脉微循环障碍的临床研究[J].中国急救复苏与灾害医学杂志,2022,17(1):98-101,106.
[8] 李芃琪,信琪琪,袁蓉,等.麝香保心丸调控冠心病血管新生的研究进展[J].中国实验方剂学杂志,2022,28(14):242-253.
[9] 李慧敏,余娟,袁清茹,等.麝香通心滴丸联合伊伐布雷定治疗老年稳定型心绞痛的临床研究[J].现代药物与临床,2022,37(1):95-98.
[10] 戴雅琴,童欢,程冰洁.麝香保心丸联合辛伐他汀对冠心病心绞痛患者血清IL-18、VEGF、T-SOD水平的影响[J].中华中医药学刊,2022,40(1):188-192.
[11] 李昱璋,欧雅莉,张雅楠,等.麝香保心丸治疗冠心病心绞痛并轻中度焦虑抑郁状态患者疗效观察[J].现代中西医结合杂志,2022,31(8):1062-1066.
[12] 赵建才,杨娅娟,田玉静.麝香保心丸治疗寒凝心脉型稳定型心绞痛的效果及对炎性因子CD31、CD62P的影响[J].河北医药,2022,44(4):516-519.
[13] 黄静静,陈浩,李霖睿,等.麝香保心丸联合冠脉内注射尼可地尔对STEMI患者PPCI术后心肌血流灌注及近期预后的影响[J].药学实践杂志,2022,40(1):79-83.
[14] 潘方瑛,范晓涛,黄丙勇.麝香保心丸联合美托洛尔治疗老年冠心病稳定性心绞痛临床研究[J].新中医,2022,54(4):43-46.
[15] 包金丽,林琳,郝园园,等.体外反搏联合麝香保心丸治疗冠状动脉3支病变的疗效观察[J].中西医结合心脑血管病杂志,2022,20(15):2798-2800.
[16] 赖思佳,王显,李天力,等.麝香保心丸治疗微血管性心绞痛的系统评价[J].中国循证心血管医学杂志,2022,14(6):658-663.
[17] 孙粼希,高阳,谢雁鸣,等.丹参川芎嗪注射液治疗冠心病合并高血压的临床用药特征——一项真实世界研究[J].海南医学院学报,2022,28(17):1320-1326.
[18] 吴宗贵,马丽红,段文慧,等.活心丸(浓缩丸)治疗冠心病慢性稳定性心绞痛(气虚血瘀证)多中心随机双盲临床研究[J].中国中西医结合杂志,2022,42(6):672-679.
[19] 陈保增,冯明静,常方圆,等.麝香保心丸对冠状动脉微循环障碍病人血管内皮功能的影响[J].中西医结合心脑血管病杂志,2022,20(1):182-184.
[20] 王建爱,胡建秀,于蕾,等.麝香通心滴丸治疗高龄冠心病并肺部感染患者的疗效及对IL-6、PCT水平的影响[J].临床和实验医学杂志,2021,20(8):830-833.